Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Ann Thorac Surg. 2015 Apr 16;99(6):1906–1913. doi: 10.1016/j.athoracsur.2015.02.022

Table 6.

Peri- and postoperative outcomes of patients receiving surgery at our institution for clinical Stage I NSCLC at early versus delayed time points.

Outcomes Surgery < 8 weeks (n=522, 54%) Surgery ≥ 8 weeks (n=449, 46%) P value

Resection type
Sublobar 74 (14%) 103 (23%) 0.001
Lobectomy 403 (77%) 324 (72%)
Bilobectomy 25 (5%) 12 (3%)
Pneumonectomy 20 (4%) 10 (2%)

Air leak 59 (11%) 43 (10%) 0.402

Pneumonia 33 (6%) 51 (11%) 0.006

Arrhythmia 94 (18%) 79 (18%) 0.933

Deep Vein Thrombosis 8 (2%) 13 (3%) 0.185

Blood transfusion 18 (3%) 39 (9%) 0.001

Myocardial infarction 5 (1%) 1 (0.2%) 0.225

Wound infection 4 (1%) 5 (1%) 0.740

Respiratory failure 27 (5%) 44 (10%) 0.006

Reintubation 23 (4%) 34 (8%) 0.040

Renal failure 9 (2%) 11 (2%) 0.500

Mean length of stay, days 6.2 ± 5.8 7 ± 9.3 0.083

Mortality 6 (1.1%) 14 (3.1%) 0.040

Readmission 30 days from discharge 26 (5%) 32 (7%) 0.221

Median survival, months 97.5 (0.2 – 168.6) 90.5 (0-172.8)